CliffBio
biologic

Lerochol

lerodalcibep-liga

Loss of exclusivityDecember 2037projected — 12-year biologic exclusivity estimate
CompanyLib →See this company's full patent-cliff portfolio

Drug detail

Brand nameLerochol
Active ingredientlerodalcibep-liga
Strength300MG/1.2ML (250MG/ML)
Dosage formInjection
RouteSubcutaneous
ModalityBiologic
FDA approvalDecember 2025
Marketing statusRx

Source: FDA Purple Book, layered on the CliffBio company graph. Cliff dates are the projected — 12-year biologic exclusivity estimate; estimates are projections, not legal advice.